Investors in Science

Venture arm of defence consultancy Techmodal.Techmodal is an applied data science business that offers expert consultancy, cost modeling, analytics, and software development services across Defence, Commercial, and Public Sectors. With a reputation for excellence in solving complex data problems.

Bayer Open Innovation's global innovation networks service offering enables clients to design, build and optimize innovation on a global scale through the creation of innovation networks that combine R&D, market intelligence, and local talent and resources.

Leaps by Bayer invests in paradigm-shifting advances in the life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough. The firm's approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.

LBBW VC founded in 1998 as an independent subsidiary of the Landesbank Baden-Wuerttenberg, LBBW Venture invests in early and late growth stages of companies. Apart from long term financial support for its portfolio companies, the team offers special commercial support by active introductions to LBBW’s fast corporate client network, pitch sessions with potential commercial clients or direct applications within the bank itself. They have a broad successful international investment track record and growth support experience given their investments in over 60 companies.

Airstream Ventures is a corporate venturing and investment company focused on technology-driven businesses within sport, healthcare, education, and their adjacencies.

HSBC Provides banking and financial services organizations. It serve approximately 40 million customers through our global businesses: Wealth and Personal Banking, Commercial Banking, and Global Banking & Markets. Our network covers 64 countries and territories in Europe, Asia, the Middle East and Africa, North America and Latin America.

Brightlands Life Sciences Ventures is a corporate venture arm of Brightlands Maastricht Health Campus.Brightlands is a network of four innovation campuses in Limburg, where researchers, entrepreneurs, and students collaborate to develop sustainable solutions in materials, health, and nutrition.

Embed Capital offers financial and strategic consulting services to startups and SMEs, supporting digitalization and managing a diverse portfolio of over 20 investments.

Genextra is a privately owned holding company with investments in early-stage life science companies. Our mission is to identify innovative research in life science and to advance novel therapies and tools by creating successful business initiatives.

Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our founders in accelerating their development. We invest in people, believing that a strong and dedicated team is one of the most important factors in the success of our investments. We aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor.

Cur8 Capital is a trading name of IFG.VC Limited, a subsidiary of Islamicfinanceguru Limited. IFG.VC Limited is authorised and regulated by the FCA (No. 943736). Cur8 Capital provides a platform showcasing various investment opportunities, though it does not promote any specific investment to the public. The information presented is meant to demonstrate the types of investments available. Detailed campaigns are accessible to authorised investors on the Cur8 Capital platform. Investment activities are confined to the United Kingdom, and potential investors outside the UK should verify local regulations. This page does not offer financial or tax advice, as tax treatment varies per individual circumstances and may change.

HERmesa is an investment club designed for both new and experienced early-stage investors interested in supporting exceptional startups founded by women. The platform aims to empower female entrepreneurs by providing them with access to capital and strategic support. HERmesa focuses on backing startups at the early stages of their development, fostering innovation and diversity within the entrepreneurial ecosystem. By bringing together a community of investors committed to gender diversity and innovation, HERmesa plays a crucial role in advancing opportunities for female founders in the startup landscape.